Loading...
Patient-derived tumour xenografts for breast cancer drug discovery
Despite remarkable advances in our understanding of the drivers of human malignancies, new targeted therapies often fail to show sufficient efficacy in clinical trials. Indeed, the cost of bringing a new agent to market has risen substantially in the last several decades, in part fuelled by extensiv...
Na minha lista:
| Udgivet i: | Endocr Relat Cancer |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Bioscientifica Ltd
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5118939/ https://ncbi.nlm.nih.gov/pubmed/27702751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-16-0251 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|